Corneal Cross Linking and Topography Guided Excimer Laser Treatment
Topography Guided Excimer Laser Surface Ablation in Combination With Corneal Cross-linking (CCL) in Patients With Progressive Ectatic Corneal Disorders.
Sponsor: Medical University of Vienna
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Medical University of Vienna
Listed as NCT01682993, this PHASE3 trial focuses on Keratoconus and Pellucid Marginal Degeneration and remains terminated or withdrawn. Sponsored by Medical University of Vienna, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
May 2017 — Jun 2018 [monthly]
Terminated PHASE3
Status: Unknown Status → Terminated
▶ Show 1 earlier version
-
Jan 2017 — May 2017 [monthly]
Unknown Status PHASE3
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical University of Vienna
For direct contact, visit the study record on ClinicalTrials.gov .